High prevalence of USA300 among clinical isolates of methicillin-resistant staphylococcus aureus on St. Kitts and Nevis, West Indies

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

High prevalence of USA300 among clinical isolates of methicillin-resistant staphylococcus aureus on St. Kitts and Nevis, West Indies. / Guardabassi, Luca; Moodley, Arshnee; Williams, Andrea; Stegger, Marc; Damborg, Peter; Halliday-Simmonds, Iona; Butaye, Patrick.

In: Frontiers in Microbiology, Vol. 10, No. JUN, 1123, 2019.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Guardabassi, L, Moodley, A, Williams, A, Stegger, M, Damborg, P, Halliday-Simmonds, I & Butaye, P 2019, 'High prevalence of USA300 among clinical isolates of methicillin-resistant staphylococcus aureus on St. Kitts and Nevis, West Indies', Frontiers in Microbiology, vol. 10, no. JUN, 1123. https://doi.org/10.3389/fmicb.2019.01123

APA

Guardabassi, L., Moodley, A., Williams, A., Stegger, M., Damborg, P., Halliday-Simmonds, I., & Butaye, P. (2019). High prevalence of USA300 among clinical isolates of methicillin-resistant staphylococcus aureus on St. Kitts and Nevis, West Indies. Frontiers in Microbiology, 10(JUN), [1123]. https://doi.org/10.3389/fmicb.2019.01123

Vancouver

Guardabassi L, Moodley A, Williams A, Stegger M, Damborg P, Halliday-Simmonds I et al. High prevalence of USA300 among clinical isolates of methicillin-resistant staphylococcus aureus on St. Kitts and Nevis, West Indies. Frontiers in Microbiology. 2019;10(JUN). 1123. https://doi.org/10.3389/fmicb.2019.01123

Author

Guardabassi, Luca ; Moodley, Arshnee ; Williams, Andrea ; Stegger, Marc ; Damborg, Peter ; Halliday-Simmonds, Iona ; Butaye, Patrick. / High prevalence of USA300 among clinical isolates of methicillin-resistant staphylococcus aureus on St. Kitts and Nevis, West Indies. In: Frontiers in Microbiology. 2019 ; Vol. 10, No. JUN.

Bibtex

@article{53a66417050d44fa9c1ee94723898431,
title = "High prevalence of USA300 among clinical isolates of methicillin-resistant staphylococcus aureus on St. Kitts and Nevis, West Indies",
abstract = "Limited information is available on antimicrobial susceptibility and clonal distribution of Staphylococcus aureus in the Caribbean region. The aims of this study were to determine the prevalence of antimicrobial resistance among S. aureus isolates and to reveal the frequency and population structure of methicillin-resistant S. aureus (MRSA) in St. Kitts and Nevis, a small island country in the West Indies. A total of 152 S. aureus isolates were collected from consecutive samples submitted to the clinical microbiology laboratory of the main referral hospital from March 2017 to January 2018. Samples came from all units in the hospital and a small number came from external submissions, and comprised a total of 119 clinical specimens and 33 nasal swabs collected from staff and patients. All S. aureus isolates were confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Minimal Inhibitory Concentrations (MICs) of clinically relevant antimicrobials were determined by broth microdilution, and diversity of MRSA isolates was assessed by whole genome sequencing (WGS) analysis. MRSA accounted for 45% (69/152) of the isolates. The highest rates of resistance to non-β-lactam agents were observed for erythromycin (55%), moxifloxacin (41%), and levofloxacin (40%), whereas resistance to the other drugs tested was .6%. All isolates were susceptible to ceftaroline, linezolid, teicoplanin, telavancin, and vancomycin. WGS-based multilocus sequence typing (MLST) showed that approximately 88% of the MRSA isolates belonged to ST8. Phylogenetic analysis on 801 single-nucleotide polymorphisms (SNPs) identified among the MRSA ST8 isolates indicates a large degree of genetic diversity. However, all ST8 strains clustered within the distinct clade that defines the USA300 North American Epidemic lineage (Panton-Valentine Leukocidin (PVL) +, arginine catabolic mobile element (ACME) +, Staphylococcal cassettes chromosome mec IVa (SCCmec IVa)). Our data show high levels of methicillin, macrolide, and fluoroquinolone resistance among S. aureus on St. Kitts and Nevis. The USA300 North American epidemic lineage is responsible for the vast majority of MRSA infections on this Caribbean island.",
keywords = "Antimicrobial resistance, Clinical, MRSA, USA300, Whole genome sequencing",
author = "Luca Guardabassi and Arshnee Moodley and Andrea Williams and Marc Stegger and Peter Damborg and Iona Halliday-Simmonds and Patrick Butaye",
year = "2019",
doi = "10.3389/fmicb.2019.01123",
language = "English",
volume = "10",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S.A.",
number = "JUN",

}

RIS

TY - JOUR

T1 - High prevalence of USA300 among clinical isolates of methicillin-resistant staphylococcus aureus on St. Kitts and Nevis, West Indies

AU - Guardabassi, Luca

AU - Moodley, Arshnee

AU - Williams, Andrea

AU - Stegger, Marc

AU - Damborg, Peter

AU - Halliday-Simmonds, Iona

AU - Butaye, Patrick

PY - 2019

Y1 - 2019

N2 - Limited information is available on antimicrobial susceptibility and clonal distribution of Staphylococcus aureus in the Caribbean region. The aims of this study were to determine the prevalence of antimicrobial resistance among S. aureus isolates and to reveal the frequency and population structure of methicillin-resistant S. aureus (MRSA) in St. Kitts and Nevis, a small island country in the West Indies. A total of 152 S. aureus isolates were collected from consecutive samples submitted to the clinical microbiology laboratory of the main referral hospital from March 2017 to January 2018. Samples came from all units in the hospital and a small number came from external submissions, and comprised a total of 119 clinical specimens and 33 nasal swabs collected from staff and patients. All S. aureus isolates were confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Minimal Inhibitory Concentrations (MICs) of clinically relevant antimicrobials were determined by broth microdilution, and diversity of MRSA isolates was assessed by whole genome sequencing (WGS) analysis. MRSA accounted for 45% (69/152) of the isolates. The highest rates of resistance to non-β-lactam agents were observed for erythromycin (55%), moxifloxacin (41%), and levofloxacin (40%), whereas resistance to the other drugs tested was .6%. All isolates were susceptible to ceftaroline, linezolid, teicoplanin, telavancin, and vancomycin. WGS-based multilocus sequence typing (MLST) showed that approximately 88% of the MRSA isolates belonged to ST8. Phylogenetic analysis on 801 single-nucleotide polymorphisms (SNPs) identified among the MRSA ST8 isolates indicates a large degree of genetic diversity. However, all ST8 strains clustered within the distinct clade that defines the USA300 North American Epidemic lineage (Panton-Valentine Leukocidin (PVL) +, arginine catabolic mobile element (ACME) +, Staphylococcal cassettes chromosome mec IVa (SCCmec IVa)). Our data show high levels of methicillin, macrolide, and fluoroquinolone resistance among S. aureus on St. Kitts and Nevis. The USA300 North American epidemic lineage is responsible for the vast majority of MRSA infections on this Caribbean island.

AB - Limited information is available on antimicrobial susceptibility and clonal distribution of Staphylococcus aureus in the Caribbean region. The aims of this study were to determine the prevalence of antimicrobial resistance among S. aureus isolates and to reveal the frequency and population structure of methicillin-resistant S. aureus (MRSA) in St. Kitts and Nevis, a small island country in the West Indies. A total of 152 S. aureus isolates were collected from consecutive samples submitted to the clinical microbiology laboratory of the main referral hospital from March 2017 to January 2018. Samples came from all units in the hospital and a small number came from external submissions, and comprised a total of 119 clinical specimens and 33 nasal swabs collected from staff and patients. All S. aureus isolates were confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Minimal Inhibitory Concentrations (MICs) of clinically relevant antimicrobials were determined by broth microdilution, and diversity of MRSA isolates was assessed by whole genome sequencing (WGS) analysis. MRSA accounted for 45% (69/152) of the isolates. The highest rates of resistance to non-β-lactam agents were observed for erythromycin (55%), moxifloxacin (41%), and levofloxacin (40%), whereas resistance to the other drugs tested was .6%. All isolates were susceptible to ceftaroline, linezolid, teicoplanin, telavancin, and vancomycin. WGS-based multilocus sequence typing (MLST) showed that approximately 88% of the MRSA isolates belonged to ST8. Phylogenetic analysis on 801 single-nucleotide polymorphisms (SNPs) identified among the MRSA ST8 isolates indicates a large degree of genetic diversity. However, all ST8 strains clustered within the distinct clade that defines the USA300 North American Epidemic lineage (Panton-Valentine Leukocidin (PVL) +, arginine catabolic mobile element (ACME) +, Staphylococcal cassettes chromosome mec IVa (SCCmec IVa)). Our data show high levels of methicillin, macrolide, and fluoroquinolone resistance among S. aureus on St. Kitts and Nevis. The USA300 North American epidemic lineage is responsible for the vast majority of MRSA infections on this Caribbean island.

KW - Antimicrobial resistance

KW - Clinical

KW - MRSA

KW - USA300

KW - Whole genome sequencing

U2 - 10.3389/fmicb.2019.01123

DO - 10.3389/fmicb.2019.01123

M3 - Journal article

C2 - 31231318

AN - SCOPUS:85068996969

VL - 10

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

IS - JUN

M1 - 1123

ER -

ID: 226493368